Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung Cancer
Clinical trial NCT03450330 · COMPLETED
Trial details
- NCT number
- NCT03450330
- Sponsor
- Dizal Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-16
- Primary completion
- 2019-09-03
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.